0001209191-20-036824.txt : 20200615
0001209191-20-036824.hdr.sgml : 20200615
20200615201213
ACCESSION NUMBER: 0001209191-20-036824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200612
FILED AS OF DATE: 20200615
DATE AS OF CHANGE: 20200615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hardiman Roy C.
CENTRAL INDEX KEY: 0001506218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38653
FILM NUMBER: 20964689
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Principia Biopharma Inc.
CENTRAL INDEX KEY: 0001510487
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263487603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 416-7700
MAIL ADDRESS:
STREET 1: 220 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-12
0
0001510487
Principia Biopharma Inc.
PRNB
0001506218
Hardiman Roy C.
C/O PRINCIPIA BIOPHARMA INC.
220 E. GRAND AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Business Officer
Common Stock
2020-06-12
4
M
0
5000
4.7236
A
122761
D
Common Stock
2020-06-12
4
S
0
1595
59.9003
D
121166
D
Common Stock
2020-06-12
4
S
0
2542
61.6169
D
118624
D
Common Stock
2020-06-12
4
S
0
863
62.1289
D
117761
D
Common Stock
1916
I
See footnote
Employee Stock Option (right to buy)
4.7236
2020-06-12
4
M
0
5000
0.00
D
2025-02-25
Common Stock
5000
2758
D
Includes 858 shares shares acquired under the Employment Stock Purchase Plan on May 15, 2020.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Represents the weighted average sales price per share. The shares sold at prices ranging from $59.41 to $60.23 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $61.00 to $61.98 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Represents the weighted average sales price per share. The shares sold at prices ranging from $62.03 to $62.63 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares indirectly held by Roy Hardiman, as custodian for his minor child under California Uniform Transfers to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
The stock option is fully vested and immediately exercisable.
/s/ Christopher Y. Chai, Attorney-in-Fact for Roy Hardiman
2020-06-15